Table 1.
Covariate | HR | 95% CI | p-value* |
---|---|---|---|
treatment arm | 0.47 | 0.32–0.70 | 0.0002 |
WRN methylation status | 0.36 | 0.14–0.98 | 0.05 |
previous adjuvant therapy | 1.65 | 1.09–2.50 | 0.02 |
serum LDH | 1.52 | 1.07–2.15 | 0.02 |
WHO performance status | 1.18 | 0.89–1.56 | 0.26 |
gender | 0.74 | 0.52–1.04 | 0.09 |
age | 0.99 | 0.98–1.01 | 0.51 |
location of metastases | 1.10 | 0.85–1.43 | 0.45 |
interaction of treatment arm and WRN methylation status | 2.11 | 1.13–3.92 | 0.02 |
Analysis based on 182 samples, of which 179 events (1 observation deleted due to missingness)
CI, confidence interval; HR, hazard ratio; WRN, Werner gene; LDH, Lactate dehydrogenase; WHO, World Health Organisation
Wald test